We need to establish a clinical relationship, document your medical history, and have your provider attest to the BMI criterion at the time therapy starts
UC, ulcerative colitis patients
10.1046/j.1365-313X.2003.01901.x Plant J
In the SURPASS-CVOT trial, patients 40 years of age or older with type 2 diabetes, a BMI of at least 25, and atherosclerotic cardiovascular disease were randomly assigned to receive a weekly subcutaneous injection of tirzepatide (up to 15 mg) or dulaglutide (1.5 mg), a GLP-1 receptor agonist that has been shown to reduce the incidence of cardiovascular events
The human APOE gene encodes the 34-kDa lipid-binding protein ApoE, which mediates lipid transport throughout peripheral organs and between brain cells (Reiman et al., 2020)
For indexed literature and PubMed research on Retatrutide signaling, consult PubMed Retatrutide Citations